99nicu... Your Forum in Neonatology!

Welcome to 99nicu, the web community for staff in neonatal medicine!

Become a member for full access to all features: get and give advice in the forums, start your own blog and enjoy benefits! Registration is free :) - click here to register!

Greetings from the 99nicu HQs

hehady

Moderators
  • Content count

    148
  • Joined

  • Last visited

  • Days Won

    5
  • Country

    Egypt

hehady last won the day on September 7 2016

hehady had the most liked content!

Community Reputation

20 Excellent

2 Followers

About hehady

  • Rank
    99nicu Team

Profile Information

  • First name
    Hesham
  • Last name
    Abdel-Hady
  • Occupation
    assistant Prof
  • Affiliation
    Mansoura University Children's Hospital
  • Location
    Mansoura, Egypt
  1. In this book, you'll learn multiple new aspects of respiratory management of the newborn. For example, ventilator management of infants with unusually severe bronchopulmonary dysplasia and infants with omphalocele is discussed, as well as positioning of endotracheal tube in extremely low birth weight infants, noninvasive respiratory support, utilization of a protocol-driven respiratory management, and more. This book includes a chapter on noninvasive respiratory function monitoring during chest compression, analyzing the efficacy and quality of chest compression and exhaled carbon dioxide. It also provides an overview on new trends in the management of fetal and transitioning lungs in infants delivered prematurely. Lastly, the book includes a chapter on neonatal encephalopathy treated with hypothermia along with mechanical ventilation. The interaction of cooling with respiration and the strategies to optimize oxygenation and ventilation in asphyxiated newborns are discussed. The book is open access free to download I hope it will be of benefit to all neonatal intensivists
  2. HHHFNC is not safe for ELBW infants?

     

    A recent large study including retrospective data analysis from the Alere Neonatal Database (USA) for infants born between January 2008 and July 2013, weighing ≤1000 g at birth, and received HFNC or CPAP was published. The study showed that HHHFNC in extremely low birth weight infants is associated with a higher risk of death or BPD, increased respiratory morbidities, delayed oral feeding, and prolonged hospitalization. The authors called for a large clinical trial to evaluate long-term safety and efficacy of HFNC in preterm infants

    Taha DK, Kornhauser M, Greenspan JS, Dysart KC, Aghai ZH. High Flow Nasal Cannula Use Is Associated with Increased Morbidity and Length of Hospitalization in Extremely Low Birth Weight Infants. J Pediatr. 2016 Mar 19. pii:
    S0022-3476(16)00273-0. doi: 10.1016/j.jpeds.2016.02.051

  3. We have published this review article recently 676192.pdf
  4. we use heparin flush 0.5ml/h
  5. The final program of the 2nd Evidence-based Neonatology Conference 13-16 March 2013, Istanbul-Turkey is now avaialble. http://www.ebneo2013.com/program.html See you there 7- Program.doc
  6. Dear Sameh You can enjoy a reduced registartion fee of 450 USD to attend the conference. Of course you have to make your own travel and accomodation plans. regards Hesham Abdel-Hady

  7. Unfortunately, I could not make it this year. Let me remind our colleagues that we will have the 2nd EBNEO conference in Cairo Next March
  8. Also abstract submission is open now. Selected research works will be presented as posters as well as short oral communications. Hoping to see you all in Cairo next March.
  9. For further information please contact the Project Manager Susan Smith – sls1@soton.ac.uk
  10. Dear colleagues A great chance to enhance your professional development as a neonatologist and get a potential to get a postgraduate certificate , a diploma, or a Master degree in Neonatology through online training. The is recognised by ESPR ESN and Univeristy of south Hampton UK . The course will start soon next October
  11. Promising but very expensive (not for developing countries), may be Hypothermia + Erythopoietin is more affordable (our center will report results of a recent trial soon).